American College of Medical Genetics & Genomics (ACMG) Annual Clinical Genetics Meeting 2016

Tampa, FL
March 10, 2016
  • Robert C. Green, MD, MPH
  • Kurt Christensen, PhD
  • Heidi Rehm, PhD, FACMG
  • Daiva Nielsen, PhD
  • Lily Hoffman-Andrews
  • Rebecca Walsh
  • Ozge Ceyhan-Birsoy, PhD
Pro/Con: The Debate Around Direct-Access-Testing

The Genomes2People team and our collaborators presented data from a number of our key projects at the American College of Medical Genetics and Genomics (ACMG) 2016 Annual Clinical Genetics Meeting from March 8 to 12 in Tampa, FL.

 

Wednesday, March 9

8:00am-9:30am: G2P director Robert C. Green, MD, MPH, will present as part of the Satellite Symposium “The Rising Tide of Patient Initiated Testing: What are the Consequences for Patients and Health Professionals?” at the Marriott Tampa Waterside in Grand Ballroom A-E.

  • Dr. Green will present on “Personal Genome Testing: Comprehension and Consequences.”

 

Thursday, March 10

10:30am-12:00pm: G2P team members and collaborators will be presenting posters with data from G2P projects in the East Exhibit Hall.

  • Kurt Christensen, PhD, Instructor at Brigham & Women’s and Harvard Medical School, will present data from the MedSeq Project in his poster “Using Whole Genome Sequencing to Motivate Lifestyle Changes: Preliminary Findings from the MedSeq Project” (663).
  • Lily Hoffman-Andrews, Research Assistant, will also present data from MedSeq in her poster “The Association of Monogenic Findings from Whole Genome Sequencing with Known Phenotypes: 4 Case Studies” (259).
  • Rebecca Walsh, Research Assistant, will present data from the BabySeq Project in her poster “Experiences and Lessons from the BabySeq Project about Parents’ Interest in Newborn Genomic Sequencing” (473).
  • Yue Guan, MS, CGC, a G2P collaborator, will present data from the REVEAL Study in her poster “Disclosing Genetic Risk of Alzheimer’s Disease to Cognitively Impaired Patients and Visit Companions: Findings from The REVEAL Study” (445).

4:15pm – 5:45pm:  Dr. Green will present as part of the Robert C. Baumiller Symposium “Pro/Con: The Debate Around Direct-Access-Testing” in the Central Exhibit Hall.

  • Dr. Green will present the perspective “Emerging Empirical Data Show No Evidence of Harm.”

 

Friday, March 11

10:30am – 12:00pm: G2P team members and collaborators will be presenting posters with data from G2P projects in the East Exhibit Hall.

  • Daiva Nielsen, PhD, post-doctoral research fellow with G2P, will present data from the PeopleSeq Consortium in her poster “Health Information-seeking as a Result of Predispositional Genome Sequencing: Findings from the PeopleSeq Consortium” (228).
  • J. Scott Roberts, PhD, a G2P collaborator, will present data from MedSeq in his poster “Patient Understanding and Satisfaction Regarding the Clinical Use of Whole Genome Sequencing: Findings from the MedSeq Project” (430).
  • Allison Cirino, MS, CGC, a G2P collaborator, will present data from MedSeq in her poster “Investigating the Utility of Whole Genome Sequencing in Hypertrophic Cardiomyopathy Patients” (510).
  • Heidi Rehm, PhD, a G2P collaborator, will present data from the CSER Consortium, of which MedSeq is a part, in her poster “Performance of the ACMG/AMP Variant Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research (CSER) Consortium” (482).

3:45pm – 4:00pm: G2P collaborator Ozge Birsoy, PhD, will present data from BabySeq as part of a platform presentation session on whole exome sequencing in Ballroom AB.

  • Dr. Birsoy will present her abstract “Genomic Sequencing in Newborns: Early Sequencing Results from the BabySeq Project.”

Latest News From Genomes2People